Workflow
医学研究及科研成果转化
icon
Search documents
百洋医药:与首都医科大学宣武医院建立了“神经网络疾病协同创新联合实验室”
Xin Lang Cai Jing· 2026-01-06 01:52
Core Viewpoint - Baiyang Pharmaceutical has established collaborative innovation laboratories with Xuanwu Hospital of Capital Medical University, focusing on cutting-edge medical research and the transformation of scientific achievements in neuroscience and thoracic surgery [1] Group 1: Collaboration and Research Initiatives - Baiyang Pharmaceutical and Xuanwu Hospital have created the "Xuanwu-Baiyang Pharmaceutical Neuroscience Collaborative Innovation Laboratory" and the "Xuanwu-Baiyang Pharmaceutical Thoracic Disease Laboratory" [1] - The collaboration aims to conduct advanced medical research and facilitate the application of research outcomes in key areas such as neuroscience and thoracic surgery [1] Group 2: Recognition and Support - The Beijing Municipal Science and Technology Commission and the Management Committee of Zhongguancun Science Park have recently announced the new batch of key laboratories for 2025 [1] - The brain-machine interface and neural regulation treatment laboratory for brain diseases, applied by Xuanwu Hospital, has been approved as a key laboratory in Beijing, with Professor Zhao Guoguang appointed as the laboratory director [1]